Regulation of apolipoprotein A-I gene expression by the histamine H1 receptor: Requirement for NF-κB

Life Sciences
Michael J HaasArshag D Mooradian

Abstract

Earlier it had been found by us that apolipoprotein A-I (apo A-I) is suppressed by histamine in HepG2 cells. Histamine has been shown to regulate NF-κB activity, though not in hepatocytes. Therefore we examined the role of the histamine receptors and NF-κB in histamine-mediated apo A-I gene expression in HepG2 liver cells. The effect of histamine on histamine H1 receptor expression, and NF-κB p65 and p50 subunits was examined by Western blot. Histamine H1 receptor involvement was examined by loss-of-function (via siRNA) and gain-of-function studies overexpressing the histamine H1 receptor. The requirement for the p65 subunit of NF-κB for histamines effect was elucidated by loss-of-function studies (siRNA). Finally, the effect of histamine on NF-κB binding to the apo A-I gene promoter was examined by chromatin immunoprecipitation. Treatment of HepG2 cells with histamine had no effect on histamine H1 receptor expression. However, treatment with histamine increased NF-κB p65 and p50 subunit expression significantly. At low levels, the exogenous histamine H1 receptor plasmid suppressed apo A-I gene promoter activity while addition of higher levels of plasmid DNA actually increased apo A-I gene promoter activity. Inhibition of NF-κB...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M LeeP T Kovanen
Aug 1, 1990·Analytical Biochemistry·J Alam, J L Cook
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard
Jun 8, 2001·The Journal of Clinical Investigation·G MartinB Staels
Mar 2, 2002·The Journal of Biological Chemistry·Joelle HillionKjell Fuxe
Dec 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Miriam LeePetri T Kovanen
Oct 24, 2003·Biochimica Et Biophysica Acta·Michael J HaasArshag D Mooradian
Mar 24, 2005·Journal of Molecular Neuroscience : MN·Maria TorvinenLuigi F Agnati
Sep 1, 2006·Trends in Endocrinology and Metabolism : TEM·Gabriel Pascual, Christopher K Glass
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jul 12, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew J MurphyJaye Chin-Dusting
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Nov 17, 2011·The New England Journal of Medicine·William E BodenWilliam Weintraub
Nov 7, 2012·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN dal-OUTCOMES Investigators
Jul 9, 2013·European Journal of Pharmacology·Federico MonczorCarlos Davio
Jan 28, 2014·Cardiovascular Diabetology·Jean-Charles FruchartUNKNOWN Residual Risk Reduction Initiative (R3i)
Jan 24, 2015·Nature Reviews. Immunology·Alan R Tall, Laurent Yvan-Charvet
Apr 11, 2015·Methods in Enzymology·Raja ChakrabortyPrashen Chelikani
Jul 21, 2015·Current Opinion in Cardiology·Hasan K SiddiqiDaniel Rader
Dec 19, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Su Duy NguyenPetri T Kovanen
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Dec 18, 2019·International Journal of Molecular Sciences·Violeta G TruscaAnca V Gafencu
Feb 6, 2020·Drugs·Julien J Feghaly, Arshag D Mooradian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.